Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 282 articles:
HTML format



Single Articles


    May 2024
  1. CHEN ML, Rezaei SJ, Kim J, Rodriguez C, et al
    Incidence of Suicide Among Melanoma and Non-Keratinocyte Skin Cancer Patients in the US, 2000-2020.
    J Am Acad Dermatol. 2024 May 18:S0190-9622(24)00787.
    PubMed    


  2. BRODELL RT
    JAAD Game Changers: "Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology".
    J Am Acad Dermatol. 2024 May 18:S0190-9622(24)00795.
    PubMed    


  3. SHAH P, Trepanowski N, Grant-Kels JM, LeBoeuf M, et al
    Mohs Micrographic Surgery in the Surgical Treatment Paradigm of Melanoma In Situ and Invasive Melanoma: A Clinical Review of Treatment Efficacy and Ongoing Controversies.
    J Am Acad Dermatol. 2024 May 18:S0190-9622(24)00756.
    PubMed     Abstract available


  4. FREEMAN SC, Paz Munoz E, Latour E, Lim JY, et al
    Response to Prieto et al., "RE: External validation of the Melanoma Institute Australia Sentinel Lymph Metastasis Risk Prediction Tool using the National Cancer Database".
    J Am Acad Dermatol. 2024 May 11:S0190-9622(24)00733.
    PubMed    


  5. PRIETO PA, Goldberg MS, Martin B
    RE: External validation of the Melanoma Institute Australia Sentinel Lymph Metastasis Risk Prediction Tool using the National Cancer Database.
    J Am Acad Dermatol. 2024 May 9:S0190-9622(24)00735.
    PubMed    


    April 2024
  6. KOGA S, Du W, Ono D
    Response to "Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.".
    J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00671.
    PubMed    


  7. DESAI AD, Ibrahim SJ, Samie FH
    Evaluating the benefit of immunotherapy for Stage III melanoma.
    J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00679.
    PubMed    


  8. MONNIER J, Gouabou Foahom AC, Serdi M, Collenne J, et al
    Automated melanoma detection. An algorithm inspired from human intelligence characterizing disordered pattern of melanocytic lesions improving a convolutional neural network.
    J Am Acad Dermatol. 2024 Apr 11:S0190-9622(24)00630.
    PubMed    


  9. WANG E, Ahad T, Liu YA, Lee TK, et al
    Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
    J Am Acad Dermatol. 2024;90:759-766.
    PubMed     Abstract available


  10. COHEN Y, Jaberi M, Litvinov IV, Shamout Y, et al
    Novel suturing technique for reduced electrocautery in excisional procedures for non-melanoma skin cancer.
    J Am Acad Dermatol. 2024;90:e131-e132.
    PubMed    


    March 2024
  11. FUNCHAIN P, Ni Y, Heald B, Bungo B, et al
    Germline Cancer Susceptibility in Individuals with Melanoma.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00504.
    PubMed     Abstract available


  12. BANNER L, Rohan TZ, Zachian R, Gross T, et al
    Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
    PubMed    


  13. MATTHEWS NH, Hamad J, Henderson JB, Weinstock MA, et al
    Projected burden of melanoma clinical surveillance in the United States.
    J Am Acad Dermatol. 2024 Mar 8:S0190-9622(24)00476.
    PubMed    


  14. TUPPER CJ, Clausen MC, Cogua LM, Silberstein PT, et al
    Improved Survival Outcomes for Melanoma of Unknown Primary in the Era of Novel Therapies: A Population-Based Retrospective Analysis.
    J Am Acad Dermatol. 2024 Mar 6:S0190-9622(24)00446.
    PubMed    


  15. NEALE H, Plumptre I, Belazarian L, Wiss K, et al
    Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi.
    J Am Acad Dermatol. 2024;90:e107-e108.
    PubMed    


  16. GRANT-KELS JM
    JAAD Game Changer: Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    J Am Acad Dermatol. 2024;90:674.
    PubMed    


    February 2024
  17. GIULINI M, Goldust M, Grabbe S, Ludwigs C, et al
    Combining artificial intelligence and human expertise for more accurate dermoscopic melanoma diagnosis: A 2-session retrospective reader study.
    J Am Acad Dermatol. 2024 Feb 29:S0190-9622(24)00307.
    PubMed    


  18. TORTORELLO GN, Li EH, Sharon CE, Shafique N, et al
    Pathologic Characteristics and Clinical Outcomes of Primary Dermal Melanoma.
    J Am Acad Dermatol. 2024 Feb 22:S0190-9622(24)00401.
    PubMed    


  19. HUANG Y, Fleming P, Fung K, Chan AW, et al
    Association between dermatology follow-up and melanoma survival: a population-based cohort study.
    J Am Acad Dermatol. 2024 Feb 16:S0190-9622(24)00372.
    PubMed     Abstract available


  20. MORR C, Jade Prechtel T, Hardacker R, Bell M, et al
    Impact of skin cancer screening on melanoma thickness and stage.
    J Am Acad Dermatol. 2024 Feb 13:S0190-9622(24)00348.
    PubMed    


  21. KYE Y, Zhao G, Guhan S, Nunes D, et al
    Research letter: BRAF-inhibitor induced panniculitis - A systematic review.
    J Am Acad Dermatol. 2024;90:420-423.
    PubMed    


    January 2024
  22. KOOPER-JOHNSON S, Kasthuri V, Homer A, Nguyen BM, et al
    Higher Risk of Melanoma-related Deaths for Patients Residing in Rural Counties: A Surveillance, Epidemiology, and End Results Program Study.
    J Am Acad Dermatol. 2024 Jan 31:S0190-9622(24)00167.
    PubMed    


  23. CHOI ME, Jung JM, Kim DH, Won CH, et al
    Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to Non-Acral Melanoma and its Prognostic Significance.
    J Am Acad Dermatol. 2024 Jan 23:S0190-9622(24)00103.
    PubMed     Abstract available


  24. TATE JA, Matsumoto A, Greif C, Lim J, et al
    Excision Margins for Melanoma in Situ on the Head and Neck - A Single-Center 10-year Retrospective Review of Treatment with Mohs Micrographic Surgery.
    J Am Acad Dermatol. 2024 Jan 20:S0190-9622(24)00102.
    PubMed     Abstract available


  25. SHIFAI N, van Doorn R, Malvehy J, Sangers T, et al
    Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.
    J Am Acad Dermatol. 2024 Jan 18:S0190-9622(24)00076.
    PubMed    


  26. VIKSTROM S, Syriopoulou E, Andersson TM, Eriksson H, et al
    Loss in life expectancy in Patients with Stage II-III cutaneous melanoma in Sweden: a population-based cohort study.
    J Am Acad Dermatol. 2024 Jan 11:S0190-9622(24)00056.
    PubMed     Abstract available


  27. TIMURKAYNAK O, Gonenli G
    Response to Young JN et al.'s "The utility of ChatGPT in generating patient-facing and clinical responses for melanoma".
    J Am Acad Dermatol. 2024 Jan 10:S0190-9622(24)00060.
    PubMed    


  28. HEKLER A, Maron RC, Haggenmuller S, Schmitt M, et al
    Using Multiple Real-World Dermoscopic Photographs of One Lesion Improves Melanoma Classification via Deep Learning.
    J Am Acad Dermatol. 2024 Jan 8:S0190-9622(24)00048.
    PubMed    


  29. NAVARRETE-DECHENT C, Jaimes N, Dusza SW, Liopyris K, et al
    Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of lentigo maligna on the face.
    J Am Acad Dermatol. 2024;90:52-57.
    PubMed     Abstract available


    December 2023
  30. BERK-KRAUSS J, Sharma M, Polsky D, Geller AC, et al
    Cutaneous Melanoma Incidence - Evidence of a Flattening Curve.
    J Am Acad Dermatol. 2023 Dec 10:S0190-9622(23)03288.
    PubMed    


  31. HAGSTROM M, Dhillon S, Fumero-Velazquez M, Olivares S, et al
    A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study.
    J Am Acad Dermatol. 2023;89:1185-1191.
    PubMed     Abstract available


  32. KOOPER-JOHNSON SB, Weber M, Eichtadt S, Nguyen BM, et al
    Limited commercialization of artificial intelligence technology in the diagnosis of pigmented lesions despite explosive growth in published programs.
    J Am Acad Dermatol. 2023;89:1246-1248.
    PubMed    


  33. WAGNER NB, Knierim SM, Luttermann F, Metzler G, et al
    Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A
    J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03250.
    PubMed     Abstract available


  34. FERNANDEZ JM, Mata EM, Plampton K, Whitley MJ, et al
    Melanoma Characteristics and Overall Survival Predictors in American Indians and Alaska Natives: An Analysis of the National Cancer Database from 2004 to 2018.
    J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03254.
    PubMed    


    November 2023
  35. FERNANDEZ JM, Evans TD, Schissel M, Siller A Jr, et al
    Racial and ethnic differences in time to definitive surgery for melanoma: A retrospective study from the National Cancer Database.
    J Am Acad Dermatol. 2023 Nov 30:S0190-9622(23)03251.
    PubMed    


  36. PAN CX, Liu M, Lau CB, Lau WC, et al
    Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors.
    J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03239.
    PubMed    


  37. HAWRYLUK EB, Moustafa D, Barry KK, Bahrani E, et al
    Risk Factors and Outcomes of Melanoma in Children and Adolescents: A Retrospective Multicenter Study.
    J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03238.
    PubMed     Abstract available


  38. FALDETTA C, Kaleci S, Chester J, Ruini C, et al
    Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy.
    J Am Acad Dermatol. 2023 Nov 19:S0190-9622(23)03014.
    PubMed     Abstract available


  39. MAGHFOUR J, Li P, Piontkowski A, Ozog D, et al
    Melanoma Incidence and Mortality: Exploring the Impact of Regional UV Radiation and Socioeconomic Status in the Context of Breslow Thickness.
    J Am Acad Dermatol. 2023 Nov 8:S0190-9622(23)03181.
    PubMed    


  40. CLARK P, Howard H, Garrett E, Waters P, et al
    Health inequities in melanoma: A scoping review.
    J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)02892.
    PubMed    


  41. KIM DY, Swetter SM, Huhmann L, Dizon MP, et al
    Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients.
    J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)03089.
    PubMed    


  42. TOMAS-VELAZQUEZ A, Lopez-Gutierrez JC, Reyes-Mugica M, Salgado CM, et al
    Serum levels of S-100 protein are directly proportional to the size, number, thickness and degree of cellularity of congenital melanocytic nevi.
    J Am Acad Dermatol. 2023;89:1074-1077.
    PubMed    


  43. AHMED F, Fisher MJ, Snyder KM, Smith K, et al
    Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric population.
    J Am Acad Dermatol. 2023;89:1066-1068.
    PubMed    


  44. KIM DY, Christopher Dee E, Cheng I, Hartman RI, et al
    Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
    J Am Acad Dermatol. 2023 Nov 1:S0190-9622(23)03090.
    PubMed    


    October 2023
  45. EVERDELL E, Shah H, Parisi R, Feustel PJ, et al
    Non-visibility of Suspicious Lesions by Patients Leads to Later Detection of Melanoma: A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02888.
    PubMed    


  46. FERNANDEZ JM, Koblinski JE, Dahak S, Curiel-Lewandrowski C, et al
    Gender Differences in Pediatric and Adolescent Melanoma: A Retrospective Analysis of 4,645 Cases.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02866.
    PubMed     Abstract available


  47. WAN G, Leung BW, DeSimone MS, Nguyen N, et al
    Development and Validation of Time-to-Event Models to Predict Metastatic Recurrence of Localized Cutaneous Melanoma.
    J Am Acad Dermatol. 2023 Oct 3:S0190-9622(23)02881.
    PubMed     Abstract available


  48. YUMEEN S, Mirza FN, Mirza HN, Zogg CK, et al
    Malignant blue nevus: Characterization of US epidemiology and prognostic factors of a rare neoplasm with aggressive clinical course using the Surveillance, Epidemiology, and End Results Program database.
    J Am Acad Dermatol. 2023;89:843-846.
    PubMed    


  49. KRENGEL S, Ott H, Waelchli R
    Recommendations for routine magnetic resonance imaging in children with congenital melanocytic nevi need revision Comment to Neale et al., J Am Acad Dermatol. 87(5):1060-1068.
    J Am Acad Dermatol. 2023;89:e153-e154.
    PubMed    


    September 2023
  50. WEI AH, Fane LS, Tripathi R, Bordeaux JS, et al
    Differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
    J Am Acad Dermatol. 2023 Sep 26:S0190-9622(23)02868.
    PubMed    


  51. WEI AH, Zheng DX, Cullison CR, Scott JF, et al
    Incidence and characteristics of acral lentiginous melanoma in Asian Americans and Pacific Islanders.
    J Am Acad Dermatol. 2023 Sep 19:S0190-9622(23)02828.
    PubMed    


  52. TAN SX, Aung TN, Claeson M, Acs B, et al
    Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study.
    J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02833.
    PubMed    


  53. NI Y, Watts CG, Scolyer RA, Madronio C, et al
    Prognosis for people with multiple primary melanomas compared with a single primary melanoma.
    J Am Acad Dermatol. 2023 Sep 13:S0190-9622(23)02693.
    PubMed    


  54. WU Q, Pan J, Lin W, Zhao S, et al
    Clinicopathologic features, delayed diagnosis and survival in amelanotic acral melanoma: a comparative study with pigmented melanoma.
    J Am Acad Dermatol. 2023 Sep 8:S0190-9622(23)02677.
    PubMed    


  55. LIN JY, Wang J, Mishra K, Osmani S, et al
    Non-Melanoma Skin Cancer in Skin of Color Solid Organ Transplant Recipients.
    J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02678.
    PubMed    


  56. GRANT-KELS JM
    JAAD Game Changers: Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
    J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02674.
    PubMed    


  57. JILANI S, D'Amiano NM, Thompson KG, Ellis J, et al
    Factors Affecting Follow-Up Adherence Following Mohs Micrographic Surgery in Patients with Non-Melanoma Skin Cancer: A Retrospective Chart Review.
    J Am Acad Dermatol. 2023 Sep 5:S0190-9622(23)02669.
    PubMed    


  58. KIM U, Hoehn R, Schwartz GK, Cullen J, et al
    Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02659.
    PubMed    


  59. COSTELLO CM, Dusza SW, Marghoob AA, Halpern AC, et al
    Melanoma Screening and Public Education for Minority Populations in the United States.
    J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02663.
    PubMed    


  60. ANVERY N, Kang B, Christensen RE, Dirr MA, et al
    Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithms.
    J Am Acad Dermatol. 2023;89:595-597.
    PubMed    


  61. CHOI S, Mulvaney P
    Evaluating the landscape of discount and patient assistance programs for topical sunscreen products in the United States.
    J Am Acad Dermatol. 2023;89:580-582.
    PubMed    


    August 2023
  62. SORENSEN R
    Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
    J Am Acad Dermatol. 2023 Aug 26:S0190-9622(23)02633.
    PubMed    


  63. XIONG DD, Bordeaux J
    The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: a retrospective national cohort study.
    J Am Acad Dermatol. 2023 Aug 23:S0190-9622(23)02595.
    PubMed     Abstract available


  64. BRODELL RT
    Primary dermal melanoma: A unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: A clinical, histologic, and gene expression-profiling study.
    J Am Acad Dermatol. 2023 Aug 16:S0190-9622(23)02515.
    PubMed    


  65. ROSTER K, Rajeh A, Wu F, Wan G, et al
    Recurrence and Survival in Early-stage Acral Lentiginous Melanoma, A Retrospective Analysis.
    J Am Acad Dermatol. 2023 Aug 13:S0190-9622(23)02494.
    PubMed    


  66. PAN CX, Lau WC, Kim DY, Lau CB, et al
    Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation.
    J Am Acad Dermatol. 2023 Aug 8:S0190-9622(23)02422.
    PubMed    


  67. EL SHAROUNI MA, Lo SN, Scolyer RA, van Gils CH, et al
    Reply to: "Estrogen could also play a key role in the development of pediatric melanoma".
    J Am Acad Dermatol. 2023;89:e97-e98.
    PubMed    


    July 2023
  68. AMARAL T, Pop OT, Chatziioannou E, Sinnberg T, et al
    EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
    J Am Acad Dermatol. 2023 Jul 22:S0190-9622(23)02392.
    PubMed    


  69. FREEMAN SC, Munoz EP, Latour E, Lim JY, et al
    External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01350.
    PubMed     Abstract available


  70. HOANG MP, Karpinski P, Zuniga-Castillo M, Foreman RK, et al
    Histologic Margin Status is a Predictor of Relapse in Lentigo Maligna Melanoma.
    J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01349.
    PubMed     Abstract available


  71. UGWU N, Cheraghlou S, Weiss J
    Primary Merkel Cell Carcinoma Is Associated with Increased, Extended Risk of Subsequent Melanoma and Non-Epithelial Skin Cancer.
    J Am Acad Dermatol. 2023 Jul 12:S0190-9622(23)01345.
    PubMed    


  72. FERNANDEZ JM, Mata EM, Bubic BN, Kwan KR, et al
    Racial and ethnic differences in males with melanoma: A retrospective cohort study of 205,125 cases from the National Cancer Database.
    J Am Acad Dermatol. 2023 Jul 11:S0190-9622(23)01105.
    PubMed    


  73. MUNOZ EP, Patel SP, Leachman SA, Yu NY, et al
    Minority Enrollment in Melanoma Clinical Trials.
    J Am Acad Dermatol. 2023 Jul 5:S0190-9622(23)01263.
    PubMed    


  74. MEVES A, Todd A, Johnson EF
    Tumor width and calculated tumor area do not outperform Breslow thickness in predicting sentinel lymph node biopsy positivity.
    J Am Acad Dermatol. 2023;89:188-190.
    PubMed    


  75. SMITH B, Smith JE, Demanelis K, Ferris LK, et al
    Changes in skin cancer screening rates in the United States from 2005 to 2015.
    J Am Acad Dermatol. 2023;89:142-145.
    PubMed    


  76. MORGAN FC, Yehia L, McDonald C, Martinez-Agosto JA, et al
    Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
    J Am Acad Dermatol. 2023;89:90-98.
    PubMed     Abstract available


    June 2023
  77. INGRASSIA JP, Adotama P, Stein JA, Polsky D, et al
    Re-examining melanoma secondary prevention and the role of skin self-examination.
    J Am Acad Dermatol. 2023 Jun 27:S0190-9622(23)01195.
    PubMed    


  78. RYPKA KJ, Goldfarb N, Mansh M
    Response to the Feasibility of Kreher et al.'s "Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors".
    J Am Acad Dermatol. 2023 Jun 26:S0190-9622(23)01188.
    PubMed    


  79. PAN CX, Nambudiri VE
    Response to: "Response to Pan et al.'s 'Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.'".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01099.
    PubMed    


  80. BARRY R, Murray G, Hazel K, Ryan J, et al
    Response to Pan et al.'s "Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.".
    J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01100.
    PubMed    


  81. ABRANTES T, Robbins A, Kahn B, Yumeen S, et al
    Understanding melanoma in situ - lentigo maligna surgical treatment terminology and guideline adherence, a targeted review.
    J Am Acad Dermatol. 2023 Jun 10:S0190-9622(23)01084.
    PubMed     Abstract available


  82. CHANG ALS, Zaba L, Kwong BY
    Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments.
    J Am Acad Dermatol. 2023;88:1243-1255.
    PubMed     Abstract available


  83. LEUNG BW, Wan G, Nguyen N, Rashdan H, et al
    Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study.
    J Am Acad Dermatol. 2023;88:1265-1270.
    PubMed     Abstract available


    May 2023
  84. LIM RK, Weinstock MA
    Racial disparities in diagnosis of invasive melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results Program.
    J Am Acad Dermatol. 2023 May 29:S0190-9622(23)00985.
    PubMed    


  85. RAJEH A, Wan G, Roster K, Rashdan H, et al
    Underuse of sentinel lymph node biopsy for early-stage melanoma.
    J Am Acad Dermatol. 2023 May 25:S0190-9622(23)00975.
    PubMed    


  86. KO MJ, Tsai WC, Tsai PH, Hsu LY, et al
    Ultraviolet B Phototherapy Does Not Increase the Risk of Skin Cancer Among Patients with Atopic Dermatitis: A Population-Based Retrospective Cohort Study.
    J Am Acad Dermatol. 2023 May 24:S0190-9622(23)00977.
    PubMed     Abstract available


  87. HEERFORDT IM, Philipsen PA, Andersen JD, Langhans L, et al
    RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00971.
    PubMed     Abstract available


  88. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: a cross-sectional study.
    J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00969.
    PubMed     Abstract available


  89. KIM DY, Marchetti MA, Hartman RI
    Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010-2019.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00905.
    PubMed    


  90. YOUNG JN, O'Hagan R, Poplausky D, Levoska MA, et al
    The utility of ChatGPT in generating patient-facing and clinical responses for melanoma.
    J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00908.
    PubMed    


  91. ZHANG S, Tang K, Wan G, Nguyen N, et al
    Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
    J Am Acad Dermatol. 2023;88:1024-1032.
    PubMed     Abstract available


  92. JOEL MZ, Tripathi R, Scott JF
    Predictors of receipt of sentinel lymph node biopsy in patients with malignant adnexal tumors of the skin.
    J Am Acad Dermatol. 2023;88:1179-1182.
    PubMed    


  93. FELMINGHAM C, Pan Y, Kok Y, Kelly J, et al
    Improving skin cancer management with ARTificial intelligence: A pre-post intervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a real-world specialist dermatology setting.
    J Am Acad Dermatol. 2023;88:1138-1142.
    PubMed    


  94. SHI K, Zhang B, Kong BY, Zhang Y, et al
    Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
    J Am Acad Dermatol. 2023;88:1051-1059.
    PubMed     Abstract available


  95. CAI ED, Swetter SM, Sarin KY
    Association of multiple primary melanomas with malignancy risk: A population-based analysis of entries from the Surveillance, Epidemiology, and End Results program database during 1973-2014.
    J Am Acad Dermatol. 2023;88:e211-e219.
    PubMed     Abstract available


    April 2023
  96. AZOULAY L, St-Jean A, Dahl M, Quail J, et al
    Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multi-site population-based cohort study.
    J Am Acad Dermatol. 2023 Apr 25:S0190-9622(23)00735.
    PubMed     Abstract available


  97. SHANNON AB, Karakousis GC
    The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to additional multi-institution and international reports.
    J Am Acad Dermatol. 2023 Apr 22:S0190-9622(23)00732.
    PubMed    


  98. DRUMM C, Griffin C, Van Baarsel S, Quigley C, et al
    Response to Trepanowski et al.'s "Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study".
    J Am Acad Dermatol. 2023 Apr 21:S0190-9622(23)00733.
    PubMed    


  99. CHOI ME, Yang HJ, Won CH, Chang SE, et al
    Differences in the Tumor Immunity-related Gene Expression Profile Between Acral Lentiginous and Non-acral Melanoma.
    J Am Acad Dermatol. 2023 Apr 19:S0190-9622(23)00712.
    PubMed    


  100. FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al
    Disparities between Asian groups in time to melanoma treatment: a cross-sectional study.
    J Am Acad Dermatol. 2023 Apr 11:S0190-9622(23)00589.
    PubMed    


  101. HARVEY JA, Smith JF, Berry NA, Butterfield RJ, et al
    The influence of dermoscopy education over 14 years at a single institution: A retrospective cohort study.
    J Am Acad Dermatol. 2023;88:906-908.
    PubMed    


    March 2023
  102. CRUM OM, Campbell EH, Reinhart JP, Proffer SL, et al
    Incidence Trends of Melanoma among Young Adults: An Epidemiologic Study in Olmsted County, Minnesota.
    J Am Acad Dermatol. 2023 Mar 29:S0190-9622(23)00518.
    PubMed    


  103. MATA EM, Trinidad N, Blue E, Lobl M, et al
    Disparities in melanoma outcomes in urban versus rural settings: An analysis from the Nebraska Cancer Registry 2001-2016.
    J Am Acad Dermatol. 2023 Mar 20:S0190-9622(23)00450.
    PubMed    


  104. MAGNATERRA E, Zuccaro B, Magliulo M, Venturi F, et al
    Estrogen could also play a key role in the development of pediatric melanoma.
    J Am Acad Dermatol. 2023 Mar 18:S0190-9622(23)00439.
    PubMed    


  105. LIN EM, Lim RK, Lin S, Cho E, et al
    Disparities in Asian American Melanoma Diagnosis and Treatment from 1990-2014 -- Response to Zheng et al. "Poor melanoma outcomes and survival in Asian American and Pacific Islander patients".
    J Am Acad Dermatol. 2023 Mar 9:S0190-9622(23)00357.
    PubMed    


  106. KIM DY, Behbahani S, Hartman RI
    Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States.
    J Am Acad Dermatol. 2023 Mar 8:S0190-9622(23)00356.
    PubMed    


  107. VERMARIEN-WANG J, Doeleman T, van Doorn R, Mooyaart AL, et al
    Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlan
    J Am Acad Dermatol. 2023;88:602-608.
    PubMed     Abstract available


  108. TARANTINO IS, Kwak YJ, Goldberg LH, Beroukhim K, et al
    Application of a taped gauze on the gloved hand in preparation for a pressure bandage after a Mohs micrographic surgery layer.
    J Am Acad Dermatol. 2023;88:e125-e126.
    PubMed    


  109. LEE K
    JAAD Game Changers *: The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis.
    J Am Acad Dermatol. 2023;88:749.
    PubMed    


    February 2023
  110. IQBAL A, Bell MC, Merkel EA, Somani AK, et al
    The effect of tumor mitotic rate on melanoma-specific survival: A SEER population-based study of 54,598 cases.
    J Am Acad Dermatol. 2023 Feb 23:S0190-9622(23)00274.
    PubMed    


  111. NGUYEN N, Wan G, Ugwu-Dike P, Alexander NA, et al
    Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
    J Am Acad Dermatol. 2023 Feb 22:S0190-9622(23)00204.
    PubMed     Abstract available


  112. DESSINIOTI C, Plaka M, Kypreou K, Stergiopoulou A, et al
    A retrospective study of small-diameter invasive melanomas: metastasis at diagnosis and 9-year follow-up.
    J Am Acad Dermatol. 2023 Feb 21:S0190-9622(23)00267.
    PubMed    


  113. STEPHENS MR, Asdourian MS, Jacoby TV, Shah N, et al
    Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
    J Am Acad Dermatol. 2023 Feb 15:S0190-9622(23)00193.
    PubMed    


  114. WILSON BN, Shah R, Musthaq S, Vaidya T, et al
    Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma.
    J Am Acad Dermatol. 2023;88:440-442.
    PubMed    


  115. NAVARRETE-DECHENT C, Cordova M, Aleissa S, Liopyris K, et al
    Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
    J Am Acad Dermatol. 2023;88:371-379.
    PubMed     Abstract available


  116. LEE K
    JAAD Game Changers: Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
    J Am Acad Dermatol. 2023;88:517.
    PubMed    


    January 2023
  117. YOUNG JN, Nguyen TA, Freeman SC, Hill E, et al
    Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: a retrospective dual-center analysis.
    J Am Acad Dermatol. 2023 Jan 28:S0190-9622(23)00141.
    PubMed     Abstract available


  118. STULL CM, Nugent ST, Raj LK, Sobanko JF, et al
    Frequency and reliability of histologic subtype classification in invasive and in situ melanoma treated with Mohs micrographic surgery.
    J Am Acad Dermatol. 2023 Jan 17:S0190-9622(23)00082.
    PubMed    


  119. BEAL BT, Udkoff J, Aizman L, Etzkorn J, et al
    Outcomes of invasive melanoma of the head and neck treated with Mohs Micrographic Surgery - a multicenter study.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00062.
    PubMed     Abstract available


  120. OH BH, Lee S, Park JW, Lee JY, et al
    Risk of recurrence of nail unit melanoma after functional surgery versus amputation.
    J Am Acad Dermatol. 2023 Jan 12:S0190-9622(23)00063.
    PubMed     Abstract available


  121. WOJCIK KY, Hawkins M, Anderson-Mellies A, Hall E, et al
    Melanoma Survival by Age Group: Population-Based Disparities for Adolescent and Young Adult Patients by Stage, Tumor Thickness, and Insurance Type.
    J Am Acad Dermatol. 2023 Jan 4:S0190-9622(23)00003.
    PubMed     Abstract available


  122. SPACCARELLI N, Drozdowski R, Peters MS, Grant-Kels JM, et al
    Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
    J Am Acad Dermatol. 2023;88:13-20.
    PubMed     Abstract available


  123. DROZDOWSKI R, Spaccarelli N, Peters MS, Grant-Kels JM, et al
    Dysplastic nevus part I: Historical perspective, classification, and epidemiology.
    J Am Acad Dermatol. 2023;88:1-10.
    PubMed     Abstract available


  124. FARIES MB, Cochran AJ, Thompson JF
    Re: "Time to reconsider the role of sentinel lymph node biopsy in melanoma".
    J Am Acad Dermatol. 2023;88:e25-e26.
    PubMed    


  125. BEAULIEU D, Tsao H, Michaud DS, Okhovat JP, et al
    Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010.
    J Am Acad Dermatol. 2023;88:60-70.
    PubMed     Abstract available


    December 2022
  126. VALEK SA, Rousseau MA, Nelson KC, Kannler C, et al
    Melanoma risk among career firefighters: A systematic review of case-control studies.
    J Am Acad Dermatol. 2022 Dec 30:S0190-9622(22)03320.
    PubMed    


  127. ROUSSET P, Dalle S, Mortier L, Dereure O, et al
    Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
    J Am Acad Dermatol. 2022 Dec 19:S0190-9622(22)03142.
    PubMed     Abstract available


  128. HUERTA T, Swetter SM, Nehal KS, Coit DG, et al
    Current evidence does not support Mohs micrographic surgery or staged excision as equivalent to wide excision for primary cutaneous melanoma.
    J Am Acad Dermatol. 2022 Dec 16:S0190-9622(22)03308.
    PubMed    


  129. PEDERSEN EA, Harms PW, Zhao L, Andea AA, et al
    Polypoid melanoma is associated with aggressive histopathological characteristics and poor clinical prognosis: A retrospective cohort study.
    J Am Acad Dermatol. 2022 Dec 10:S0190-9622(22)03181.
    PubMed    


  130. EL SHAROUNI MA, Rawson RV, Potter AJ, Paver EC, et al
    Melanomas in children and adolescents: clinicopathologic features and survival outcomes.
    J Am Acad Dermatol. 2022 Dec 9:S0190-9622(22)03176.
    PubMed     Abstract available


    November 2022
  131. KREHER MA, Noland MMB, Konda S, Longo MI, et al
    Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids.
    J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03145.
    PubMed     Abstract available


  132. KREHER MA, Konda S, Noland MMB, Longo MI, et al
    Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors.
    J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03146.
    PubMed     Abstract available


  133. SHARON CE, Straker RJ 3rd, Gimotty PA, Chu EY, et al
    Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: a population-based analysis.
    J Am Acad Dermatol. 2022 Nov 25:S0190-9622(22)03133.
    PubMed     Abstract available


  134. KNACKSTEDT T
    Differences in Sentinel Lymph Node Biopsy Utilization in Eligible Melanoma Patients Treated with Mohs Micrographic Surgery or Wide Local Excision: A population-based logistic regression model and survival analysis.
    J Am Acad Dermatol. 2022 Nov 8. pii: S0190-9622(22)02988.
    PubMed     Abstract available


  135. VAN MOLLE P, Brochez L, Verbelen T, De Boom C, et al
    The value of measuring uncertainty in neural networks in dermoscopy.
    J Am Acad Dermatol. 2022;87:1191-1193.
    PubMed    


  136. SEIVERLING EV, Stevens K, Dorr G, Prentiss MA, et al
    Impact of multimodal dermatoscopy training on skin biopsies by primary care providers.
    J Am Acad Dermatol. 2022;87:1119-1121.
    PubMed    


    October 2022
  137. ROTH A, Boutko A, Lampley N 3rd, Olivares S, et al
    Indoor tanning is associated with an increased risk for multiple primary melanomas: A case-control study.
    J Am Acad Dermatol. 2022 Oct 30. pii: S0190-9622(22)02781.
    PubMed    


  138. RIQUELME-MC LOUGHLIN C, Sandoval-Clavijo A, de Tord MB, Boada A, et al
    Prognostic role of microsatellites in melanoma and implications in the AJCC classification system: a cohort study.
    J Am Acad Dermatol. 2022 Oct 17. pii: S0190-9622(22)02898.
    PubMed     Abstract available


  139. FERNANDEZ JM, Dahak S, Wysong A, Whitley MJ, et al
    Differences Between Asian Americans and Pacific Islanders with Cutaneous Melanoma: A Retrospective Cohort Analysis of 1,339 Cases.
    J Am Acad Dermatol. 2022 Oct 13. pii: S0190-9622(22)02887.
    PubMed    


  140. FERNANDEZ JM, Mata EM, Behbahani S, Kwan KR, et al
    Survival of Hispanic Patients with Cutaneous Melanoma: A Retrospective Cohort Analysis of 6,016 Cases from the National Cancer Database.
    J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02806.
    PubMed    


  141. ROSENTHAL A, Reddy S, Cooper R, Chung J, et al
    Disparities in Melanoma-Specific Mortality by Race/Ethnicity, Socioeconomic Status, and Healthcare Systems.
    J Am Acad Dermatol. 2022 Oct 10. pii: S0190-9622(22)02800.
    PubMed     Abstract available


  142. LEE DK, Chang MJ, Desai AD, Lipner SR, et al
    Clinical and dermoscopic findings of benign longitudinal melanonychia due to melanocytic activation differ by skin type and predict likelihood of nail matrix biopsy.
    J Am Acad Dermatol. 2022;87:792-799.
    PubMed     Abstract available


  143. JAIN M, Autuori I, Everett N, Harris U, et al
    Minimally invasive microbiopsy for genetic profiling of melanocytic lesions: A case series.
    J Am Acad Dermatol. 2022;87:903-904.
    PubMed    


  144. DELLATORRE G, Gadens GA, Polo Silveira L, Kose K, et al
    Video-based wide area digital dermoscopy.
    J Am Acad Dermatol. 2022;87:e125-e126.
    PubMed    


    September 2022
  145. SHANNON AB, Sharon CE, Straker RJ 3rd, Carr MJ, et al
    Sentinel Lymph Node Biopsy in Patients with T1a Cutaneous Malignant Melanoma: A Multi-Center Cohort Study.
    J Am Acad Dermatol. 2022 Sep 29. pii: S0190-9622(22)02783.
    PubMed     Abstract available



  146. The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe.
    J Am Acad Dermatol. 2022 Sep 24. pii: S0190-9622(22)02780.
    PubMed    


  147. WEI X, Chen Y, Yao H, Wu D, et al
    Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
    J Am Acad Dermatol. 2022 Sep 5. pii: S0190-9622(22)02627.
    PubMed     Abstract available


  148. KIM CG, Kim M, Hwang J, Kim ST, et al
    First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
    J Am Acad Dermatol. 2022 Sep 3. pii: S0190-9622(22)02443.
    PubMed     Abstract available


  149. PHAM F, Boespflug A, Duru G, Phan A, et al
    Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society.
    J Am Acad Dermatol. 2022;87:551-558.
    PubMed     Abstract available


  150. PHAM JP, Star P, Phan K, Loh Y, et al
    BRAF inhibition and the spectrum of granulomatous reactions.
    J Am Acad Dermatol. 2022;87:605-613.
    PubMed     Abstract available


    August 2022
  151. FALOTICO JM, Postow MA, Lipner SR
    Standardized guidelines for acral and nail unit melanoma treatment are lacking.
    J Am Acad Dermatol. 2022 Aug 18. pii: S0190-9622(22)02548.
    PubMed    


  152. CHERAGHLOU S, Doudican NA, Criscito MC, Stevenson ML, et al
    Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs micrographic surgery.
    J Am Acad Dermatol. 2022 Aug 17. pii: S0190-9622(22)02544.
    PubMed    


  153. KOLLA AM, Seixas A, Adotama P, Foster V, et al
    A Health Equity Framework to Address Racial and Ethnic Disparities in Melanoma.
    J Am Acad Dermatol. 2022 Aug 12. pii: S0190-9622(22)02526.
    PubMed    


  154. RAN NA, Nugent ST, Veerabagu S, Chu EY, et al
    Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery - rates of positive margins, local recurrence, and repeat surgeries.
    J Am Acad Dermatol. 2022 Aug 10. pii: S0190-9622(22)02450.
    PubMed    


  155. FERNANDEZ JM, Bubic BN, Dahak S, Mata EM, et al
    Racial and Ethnic Differences in Tumor Characteristics and Overall Survival of Women with Melanoma: A National Cancer Database Retrospective Cohort Study.
    J Am Acad Dermatol. 2022 Aug 3. pii: S0190-9622(22)02413.
    PubMed    


  156. MARCAILLOU M, Dion J, Baroudjian B, Ezrine E, et al
    Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
    J Am Acad Dermatol. 2022;87:e85-e88.
    PubMed    


  157. LEE JS, Kim S, Kim DH, Lee JW, et al
    Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea.
    J Am Acad Dermatol. 2022;87:366-372.
    PubMed     Abstract available


  158. PEREZ M, Abisaad JA, Rojas KD, Marchetti MA, et al
    Skin cancer: Primary, secondary, and tertiary prevention. Part I.
    J Am Acad Dermatol. 2022;87:255-268.
    PubMed     Abstract available


    July 2022
  159. PAN CX, Yang K, Lau CB, Zhou G, et al
    Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.
    J Am Acad Dermatol. 2022 Jul 21. pii: S0190-9622(22)02400.
    PubMed    


  160. JARELL A, Gastman BR, Dillon LD, Hsueh EC, et al
    Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.
    J Am Acad Dermatol. 2022 Jul 7. pii: S0190-9622(22)02253.
    PubMed     Abstract available


  161. MULLIGAN KM, Cullison CR, Zheng DX, Rothermel LD, et al
    Mucosal melanoma and organ-specific metastasis: Differences in survival outcomes between tumor primary sites.
    J Am Acad Dermatol. 2022 Jul 5. pii: S0190-9622(22)02248.
    PubMed    


  162. XIONG DD, Barriera-Silvestrini P, Knackstedt TJ
    Delays in surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: a population-based analysis.
    J Am Acad Dermatol. 2022 Jul 1. pii: S0190-9622(22)02239.
    PubMed     Abstract available


    June 2022
  163. TREPANOWSKI N, Chang MS, Zhou G, Ahmad M, et al
    Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study.
    J Am Acad Dermatol. 2022 Jun 20. pii: S0190-9622(22)01023.
    PubMed    


  164. CHOI ME, Won CH, Chang SE, Lee MW, et al
    Clinical and Prognostic Influence of Tumor Diameter in Acral Lentiginous Melanoma.
    J Am Acad Dermatol. 2022 Jun 17. pii: S0190-9622(22)01019.
    PubMed    


  165. ELSTON DM
    Letter from the editor: Delays in Melanoma Diagnosis.
    J Am Acad Dermatol. 2022 Jun 16. pii: S0190-9622(22)01011.
    PubMed    


  166. KUMAR AB, Peters MS, Jakub JW, Harmsen W, et al
    "Primary cutaneous melanoma features predict development of intransit metastases/satellite lesions: Mayo Clinic experience 2010-2014".
    J Am Acad Dermatol. 2022 Jun 13. pii: S0190-9622(22)00994.
    PubMed    


  167. BLUMENTHAL LY, Hu JC
    Response to "Comment on 'Racial/Ethnic disparities in non-melanoma skin cancer based on Mohs micrographic surgery defect size, a multicenter retrospective study'".
    J Am Acad Dermatol. 2022 Jun 2. pii: S0190-9622(22)00902.
    PubMed    


    May 2022
  168. KURN HA, Abercrombie M, Tzellos T, Dellavalle RP, et al
    From the Cochrane Library: Interventions for Melanoma in Situ, Including Lentigo Maligna.
    J Am Acad Dermatol. 2022 May 28. pii: S0190-9622(22)00889.
    PubMed    


  169. SCHARF C, Brancaccio G, Di Stefani A, Fargnoli MC, et al
    THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE.
    J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00812.
    PubMed    


  170. LUU YT, Goldstein AM, Sargen MR
    Variation in second cancer risk by melanoma subtype among survivors.
    J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00816.
    PubMed    


  171. SHAIKH SS, Yang X, Fortman DD, Wang H, et al
    A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma.
    J Am Acad Dermatol. 2022 May 9. pii: S0190-9622(22)00798.
    PubMed    


  172. BRUNSGAARD E, Wu YP, Grossman D
    Melanoma in Skin of Color: Part I. Epidemiology and clinical presentation.
    J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00783.
    PubMed     Abstract available


  173. BRUNSGAARD E, Jensen J, Grossman D
    Melanoma in Skin of Color: Part II. Racial disparities, role of UV, and interventions for earlier detection.
    J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00784.
    PubMed     Abstract available


  174. SARVER MM, Rames JD, Beasley GM, Gao J, et al
    Survival and Tumor Characteristics of Patients Presenting with Single Primary vs. Second Primary Melanoma Lesions.
    J Am Acad Dermatol. 2022 May 4. pii: S0190-9622(22)00715.
    PubMed     Abstract available


  175. CONDORELLI AG, Farnetani F, Ciardo S, Chester J, et al
    Dynamic dermoscopic and reflectance confocal microscopic changes of melanocytic lesions excised during follow up.
    J Am Acad Dermatol. 2022;86:1049-1057.
    PubMed     Abstract available


  176. SOENEN A, Vourc'h M, Khammari A, Nguyen JM, et al
    Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
    J Am Acad Dermatol. 2022;86:1042-1048.
    PubMed     Abstract available


    April 2022
  177. MORAES AFA, Blumetti TCMP, Pinto C, Bertoli E, et al
    Melanoma with peripheral globules: clinical and dermoscopic features.
    J Am Acad Dermatol. 2022 Apr 26. pii: S0190-9622(22)00697.
    PubMed     Abstract available


  178. STRAKER RJ 3RD, Sharon CE, Chu EY, Miura JT, et al
    Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.
    J Am Acad Dermatol. 2022 Apr 22. pii: S0190-9622(22)00681.
    PubMed     Abstract available


    March 2022
  179. HOBAYAN CGP, Grant-Kels JM, Korman AM
    The ethics of dismissing a melanoma patient who repeatedly no-shows.
    J Am Acad Dermatol. 2022 Mar 19. pii: S0190-9622(22)00504.
    PubMed    


  180. CHANG MS, La J, Trepanowski N, Cheng D, et al
    Increased relative proportions of advanced melanoma among Veterans: a comparative analysis with the SEER registry.
    J Am Acad Dermatol. 2022 Mar 9. pii: S0190-9622(22)00392.
    PubMed     Abstract available


  181. WONGVIBULSIN S, Pahalyants V, Kalinich M, Murphy W, et al
    Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
    J Am Acad Dermatol. 2022;86:563-572.
    PubMed     Abstract available


    February 2022
  182. ASDOURIAN MS, Otto TS, Jacoby TV, Shah N, et al
    Association between serum LDH and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
    J Am Acad Dermatol. 2022 Feb 19. pii: S0190-9622(22)00335.
    PubMed    


  183. EL SHAROUNI MA, Rawson RV, Sigurdsson V, Witkamp AJ, et al
    The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (>/=15mm in thickness).
    J Am Acad Dermatol. 2022 Feb 1. pii: S0190-9622(22)00174.
    PubMed     Abstract available


    January 2022
  184. PRASAD S, Black S, Chen HW, Joseph A, et al
    Beliefs and barriers to care of primary care practitioners towards melanoma screening and education in rural Texas.
    J Am Acad Dermatol. 2022 Jan 22. pii: S0190-9622(22)00091.
    PubMed    


  185. MUZUMDAR S, Wu R, Rothe MJ, Grant-Kels JM, et al
    Reflectance confocal microscopy decreases the cost of skin lesion diagnosis: A single institution retrospective chart review.
    J Am Acad Dermatol. 2022;86:209-211.
    PubMed    


    December 2021
  186. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
    Melanoma: How and When to Consider Clinical Diagnostic Technologies.
    J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02971.
    PubMed     Abstract available


  187. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
    Melanoma: An Update on Systemic Therapies.
    J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02970.
    PubMed     Abstract available


  188. GOLDSMITH SM
    Comment on "Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas".
    J Am Acad Dermatol. 2021;85:e361.
    PubMed    


  189. VASICEK B, Erickson T, Lake E
    Comment on "Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation".
    J Am Acad Dermatol. 2021;85:e351.
    PubMed    


  190. MONTAGNER S
    Reply to: "Comment on 'Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation'".
    J Am Acad Dermatol. 2021;85:e353.
    PubMed    


  191. OKHOVAT JP, Davine JA, Hawryluk EB, Geller AC, et al
    Educational brochure impact on postscreening practices of American Academy of Dermatology skin cancer screening participants.
    J Am Acad Dermatol. 2021;85:1616-1617.
    PubMed    


  192. ZAKHEM GA, Fakhoury JW, Motosko CC, Ho RS, et al
    Characterizing the role of dermatologists in developing artificial intelligence for assessment of skin cancer.
    J Am Acad Dermatol. 2021;85:1544-1556.
    PubMed     Abstract available


    November 2021
  193. KURN HA, Sivesind TE, Dellavalle RP
    From the Cochrane Library: Screening for Reducing Morbidity and Mortality in Malignant Melanoma.
    J Am Acad Dermatol. 2021 Nov 25. pii: S0190-9622(21)02909.
    PubMed    


  194. RAVAL NS, Hodges WT, Ugwu-Dike PO, Godoy F, et al
    Racial and socioeconomic differences in acral lentiginous melanoma outcomes: a SEER analysis.
    J Am Acad Dermatol. 2021 Nov 20. pii: S0190-9622(21)02856.
    PubMed    


  195. THORPE RB, Covington KR, Caruso HG, Quick AP, et al
    Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.
    J Am Acad Dermatol. 2021 Nov 19. pii: S0190-9622(21)02854.
    PubMed     Abstract available


  196. KANTOR J
    This Month in JAAD International: February 2022: Vitiligo in melanoma patients treated with anti-PD-1 therapies and improved survival.
    J Am Acad Dermatol. 2021 Nov 6. pii: S0190-9622(21)02749.
    PubMed    


  197. SOENEN A, Vourc'h M, Dreno B, Chiaverini C, et al
    Diagnosis of congenital pigmented macules in infants with reflectance confocal microscopy and machine learning.
    J Am Acad Dermatol. 2021;85:1308-1309.
    PubMed    


  198. MAZMUDAR RS, Fazio J, Garland K, Tripathi R, et al
    Predictors of patient-initiated communication after Mohs micrographic surgery: A multi-institutional prospective cohort study.
    J Am Acad Dermatol. 2021;85:1290-1293.
    PubMed    


  199. GOMEZ-MARTIN I, Collgros H, Ferguson PM, Barreiro A, et al
    Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques.
    J Am Acad Dermatol. 2021;85:1151-1160.
    PubMed     Abstract available


  200. TRIPATHI R, Bordeaux JS, Nijhawan RI
    Utilization of palliative therapy for metastatic melanoma in the United States.
    J Am Acad Dermatol. 2021;85:1342-1345.
    PubMed    


  201. CHANG MS, Huang L, Mostaghimi A, Hartman RI, et al
    Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening.
    J Am Acad Dermatol. 2021;85:1326-1328.
    PubMed    


    October 2021
  202. FARAH M, Chung HJ
    Diagnostic Utility of PRAME Immunohistochemistry in the Evaluation of Melanomas with a Co-existent Nevoid Melanocytic Population: A Single Center Retrospective Cohort Study.
    J Am Acad Dermatol. 2021 Oct 28. pii: S0190-9622(21)02714.
    PubMed    


  203. IPENBURG NA, El Sharouni MA, van Doorn R, van Diest PJ, et al
    Lack of association between CDKN2A germline mutations and survival in melanoma patients: a retrospective cohort study.
    J Am Acad Dermatol. 2021 Oct 22. pii: S0190-9622(21)02677.
    PubMed    


  204. LIN JQ, Li SQ, Li S, Kiamanesh EF, et al
    A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients.
    J Am Acad Dermatol. 2021 Oct 11. pii: S0190-9622(21)02632.
    PubMed     Abstract available


  205. LITCHMAN GH, Teplitz RW, Marson JW, Rigel DS, et al
    Impact of electrical impedance spectroscopy on dermatologists' number needed to biopsy metric and biopsy decisions for pigmented skin lesions.
    J Am Acad Dermatol. 2021;85:976-979.
    PubMed    


    September 2021
  206. GAGHAN LJ, Bui H, Lipner SR, Jellinek NJ, et al
    Evaluation of a community education tool for detection of nail melanoma by nail salon technicians.
    J Am Acad Dermatol. 2021 Sep 21. pii: S0190-9622(21)02503.
    PubMed    


  207. BLUMENTHAL LY, Arzeno J, Syder N, Rabi S, et al
    Disparities in non-melanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size, a multicenter retrospective study.
    J Am Acad Dermatol. 2021 Sep 4. pii: S0190-9622(21)02423.
    PubMed     Abstract available


  208. LALLAS A, Kyrgidis A, Manoli SM, Papageorgiou C, et al
    Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: Data from an institutional registry.
    J Am Acad Dermatol. 2021;85:721-723.
    PubMed    


    August 2021
  209. MCFEELY O, Hollywood A, Stanciu M, O'Connell M, et al
    Comment on "The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience".
    J Am Acad Dermatol. 2021 Aug 28. pii: S0190-9622(21)02383.
    PubMed    


  210. STRAKER RJ 3RD, Kelly N, Sharon CE, Shannon AB, et al
    Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis.
    J Am Acad Dermatol. 2021 Aug 12. pii: S0190-9622(21)02299.
    PubMed    


  211. YAN BY, Barilla S, Strunk A, Garg A, et al
    Survival Differences in Acral Lentiginous Melanoma According to Socioeconomic Status and Race.
    J Am Acad Dermatol. 2021 Aug 4. pii: S0190-9622(21)02210.
    PubMed     Abstract available


  212. PARISI R, Huppertz J, Potolski A, Tracey V, et al
    Distance to Diagnosing Dermatology Provider as a Predictor of Multiple Melanoma Diagnoses.
    J Am Acad Dermatol. 2021 Aug 3. pii: S0190-9622(21)02214.
    PubMed    


  213. KANTOR J
    August 2021: On the epistemology of Breslow thickness and histopathologic melanoma subtype.
    J Am Acad Dermatol. 2021;85:318.
    PubMed    


  214. WANG TS, Griffiths CC, Roman EM
    Should topical imiquimod be used for positive margins in lentigo maligna?
    J Am Acad Dermatol. 2021;85:521-522.
    PubMed    


    July 2021
  215. GAUDY-MARQUESTE C, Macagno N, Loundou A, Pellegrino E, et al
    Molecular characterization of fast-growing melanomas.
    J Am Acad Dermatol. 2021 Jul 16. pii: S0190-9622(21)02101.
    PubMed     Abstract available


  216. BUI AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al
    Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02087.
    PubMed    


  217. STRAKER RJ 3RD, Thaler AS, Shannon AB, Miura JT, et al
    Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02095.
    PubMed    


    June 2021
  218. YOO H, Kim H, Kwon ST, Jo SJ, et al
    Tumor invasion in the hyponychium is associated with distant metastasis and poor prognosis in subungual melanoma: A histological landscape of 44 cases.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01989.
    PubMed     Abstract available


  219. CARLET C, Dalle S, Leccia MT, Mortier L, et al
    Late-onset adverse events under anti-PD1 therapy in melanoma patients: an observational study from MELBASE, a nationwide prospective cohort.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01991.
    PubMed     Abstract available


  220. FIGUEROA-SILVA O, Suarez-Penaranda JM, Balboa-Barreiro V, Rojas SA, et al
    Volume tumor impact on melanoma survival assessed through Breslow density.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01107.
    PubMed    


  221. MUZUMDAR S, Lin G, Kerr P, Grant-Kels JM, et al
    Is Melanoma Overdiagnosed? A Review of the Evidence.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01110.
    PubMed     Abstract available


  222. BEAULIEU D, Gao DX, Swetter SM, Hawryluk EB, et al
    Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer(R) screening program - A cross-sectional analysis.
    J Am Acad Dermatol. 2021 Jun 2. pii: S0190-9622(21)01044.
    PubMed    


  223. VAIDYA TS, Bander TS, Musthaq S, Lampley N 3rd, et al
    Validation of a patient decision aid for the treatment of lentigo maligna.
    J Am Acad Dermatol. 2021;84:1751-1753.
    PubMed    


  224. HANLON KL, Correa-Selm LM, Grichnik JM
    Application of 3-dimensional reflectance confocal microscopy: Melanocytic proliferations as three-dimensional models.
    J Am Acad Dermatol. 2021;84:1737-1739.
    PubMed    


  225. ELSTON D
    This Month in JAAD: June 2021.
    J Am Acad Dermatol. 2021;84:1542.
    PubMed    


  226. LONGO C, Mazzeo M, Raucci M, Cornacchia L, et al
    Dark pigmented lesions: Diagnostic accuracy of dermoscopy and reflectance confocal microscopy in a tertiary referral center for skin cancer diagnosis.
    J Am Acad Dermatol. 2021;84:1568-1574.
    PubMed     Abstract available


    May 2021
  227. GREEN AC, Hughes MCB, Williams GM, Malt M, et al
    Increased melanoma recurrence in patients with multiple primary invasive melanomas.
    J Am Acad Dermatol. 2021 May 27. pii: S0190-9622(21)01012.
    PubMed    


  228. BITTAR PG, Bittar JM, Etzkorn JR, Brewer JD, et al
    Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision.
    J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00937.
    PubMed     Abstract available


  229. CHANG MS, Hartman RI
    Melanoma healthcare and outcome disparities in the Veteran Affairs population.
    J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00938.
    PubMed    


    April 2021
  230. DUNCAN JR, Srikakolapu S, Daugherty A, Elston C, et al
    Cost Efficacy of Wide Local Excision of pT1a Melanoma in Office vs. Operating Room Settings.
    J Am Acad Dermatol. 2021 Apr 28. pii: S0190-9622(21)00920.
    PubMed    


  231. GRANT-KELS JM
    JAAD Game Changers: Comparison of surgical margins for lentigo maligna versus melanoma in situ.
    J Am Acad Dermatol. 2021 Apr 21. pii: S0190-9622(21)00887.
    PubMed    


  232. MILLER CJ, Etzkorn JR, Leitenberger JJ, Bar A, et al
    Commentary on "Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting".
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00770.
    PubMed    


  233. ADALSTEINSSON JA, Stoj VJ, Algzlan H, Swede H, et al
    Limitations in the Literature Regarding Mohs Surgery and Staged Excision for Melanoma: A Critical Review of Quality and Data Reporting.
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00772.
    PubMed     Abstract available


  234. AGGARWAL P, Knabel P, Fleischer AB Jr
    United States Burden of Melanoma and Non-Melanoma Skin Cancer from 1990 to 2019.
    J Am Acad Dermatol. 2021 Apr 11. pii: S0190-9622(21)00755.
    PubMed     Abstract available


  235. OLAMIJU B, Suozzi KC, Leffell DJ, Christensen SR, et al
    Clinical Factors Impacting Clear Margins of Primary Melanoma in Situ with Conventional Excision in a Retrospective Cohort.
    J Am Acad Dermatol. 2021 Apr 10. pii: S0190-9622(21)00764.
    PubMed    


  236. HEYMANN WR
    Melanoma Healthcare and Outcome Disparities: You Can Never Be Too Rich or Too Thin.
    J Am Acad Dermatol. 2021 Apr 3. pii: S0190-9622(21)00679.
    PubMed    


  237. LUKOWIAK TM, Perz AM, Aizman L, Kovell RC, et al
    Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.
    J Am Acad Dermatol. 2021;84:1030-1036.
    PubMed     Abstract available


  238. WILLIAMS EA, Shah N, Danziger N, Montesion M, et al
    Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
    J Am Acad Dermatol. 2021;84:1069-1071.
    PubMed    


  239. MURZAKU EC, Shi K, Srivastava D, Nijhawan RI, et al
    Surgical management and practices in pregnancy and lactation: A survey of United States dermatologic surgeons.
    J Am Acad Dermatol. 2021;84:1134-1136.
    PubMed    


  240. EASON CD, Rundle C, Dunnick CA, Hugh J, et al
    National trends in free public sunscreen dispensers.
    J Am Acad Dermatol. 2021;84:1109-1111.
    PubMed    


    March 2021
  241. BAYERS S, Orseth M, Prasad S, Hynan LS, et al
    Community-based melanoma screening: A pilot study for the development of an educational curriculum for nonphysician providers.
    J Am Acad Dermatol. 2021 Mar 29. pii: S0190-9622(21)00362.
    PubMed    


  242. THOMPSON LL, Chang MS, Polyakov NJ, Blum AE, et al
    Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
    J Am Acad Dermatol. 2021 Mar 12. pii: S0190-9622(21)00563.
    PubMed    


  243. CULLISON CR, Tripathi R, Bordeaux JS
    Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma.
    J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00466.
    PubMed    


  244. PITNEY T, Muir DJ
    Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
    J Am Acad Dermatol. 2021;84:861-862.
    PubMed    


  245. MILLER RC, Stewart CR, Lipner SR
    Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19.
    J Am Acad Dermatol. 2021;84:777-779.
    PubMed    


    February 2021
  246. KOBLINSKI JE, Maykowski P, Zeitouni NC
    Disparities in melanoma stage at diagnosis in Arizona: A 10-Year Arizona Cancer Registry Study.
    J Am Acad Dermatol. 2021 Feb 20. pii: S0190-9622(21)00404.
    PubMed    


  247. GILLSTEDT M, Hedlund E, Paoli J, Polesie S, et al
    Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network.
    J Am Acad Dermatol. 2021 Feb 12. pii: S0190-9622(21)00336.
    PubMed    


  248. BRINKER TJ, Schmitt M, Krieghoff-Henning EI, Barnhill R, et al
    Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists.
    J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00331.
    PubMed    


  249. GONZALEZ-CAO M, Carrera C, Rodriguez Moreno JF, Rodriguez-Jimenez P, et al
    COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
    J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00337.
    PubMed    


  250. STRAKER RJ 3RD, Song Y, Shannon AB, Chu EY, et al
    Association of the Affordable Care Act's Medicaid Expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database Study.
    J Am Acad Dermatol. 2021 Feb 4. pii: S0190-9622(21)00308.
    PubMed     Abstract available


  251. VOGEL RI, Jewett PI, Ahmed RL, Lazovich D, et al
    Comparison of sun exposure and protection behaviors between urban and rural residents without a history of melanoma in the Midwestern United States.
    J Am Acad Dermatol. 2021 Feb 3. pii: S0190-9622(21)00304.
    PubMed    


  252. LALLAS A, Lallas K, Tschandl P, Kittler H, et al
    The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis.
    J Am Acad Dermatol. 2021;84:381-389.
    PubMed     Abstract available


    January 2021
  253. POLESIE S, Gillstedt M
    Psoriasis and risk of cutaneous melanoma: a retrospective comparative registry-based cohort study.
    J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00244.
    PubMed    


  254. SCHWAB G, Gerami P, Fiessinger L, Nardone B, et al
    A comparison of the Breslow depth and all-cause survival of male and female genital melanomas.
    J Am Acad Dermatol. 2021 Jan 28. pii: S0190-9622(21)00216.
    PubMed    


  255. TAN A, Greenwald E, Bajaj S, Belen D, et al
    Melanoma surveillance for high-risk patients via telemedicine: Examination of real-world data from an integrated store-and-forward total body photography and dermoscopy service.
    J Am Acad Dermatol. 2021 Jan 27. pii: S0190-9622(21)00206.
    PubMed    


  256. NADELMAN DA, Ahn JW, VanKoevering KK, Smith NR, et al
    Research Letter: A Single Institution's Review of Patterns of Compliance with Melanoma Ultrasound Surveillance Recommendations.
    J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00225.
    PubMed    


  257. HU X, Kilgour JM, Fogel AL, Jia JL, et al
    Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S. Cohort Study.
    J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00191.
    PubMed    


  258. VARGAS-MORA P, Peruilh-Bagolini L, Gonzalez-Cuevas R, Ferrer-Rosende P, et al
    Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2021 Jan 16. pii: S0190-9622(21)00162.
    PubMed     Abstract available


  259. BHATT MD, Perz AM, Moioli E, Sobanko JF, et al
    The accuracy of detecting melanoma on frozen section MART-1 stains and on permanent sections of previously-frozen tissue: a prospective cohort study.
    J Am Acad Dermatol. 2021 Jan 13. pii: S0190-9622(21)00008.
    PubMed    


  260. WEI C, Allais B, Tornberg HN, Quan T, et al
    The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media.
    J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00084.
    PubMed    


  261. MARSON JW, Maner BS, Harding TP, Meisenheimer J VII, et al
    The Magnitude of COVID-19's Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers.
    J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00082.
    PubMed    


  262. HARTMAN RI, La J, Chang MS, Cheng D, et al
    Risk factors for thick melanoma among Veterans: A cross-sectional study.
    J Am Acad Dermatol. 2021 Jan 7. pii: S0190-9622(21)00086.
    PubMed    


  263. MOUSTAFA D, Duncan LM, Hawryluk EB
    A 20-year histopathologic study of pediatric nevi at an academic institution.
    J Am Acad Dermatol. 2021;84:39-40.
    PubMed    


  264. LEWINSON RT, Meyers DE, Vallerand IA, Suo A, et al
    Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
    J Am Acad Dermatol. 2021;84:183-185.
    PubMed    


  265. NAVARRETE-DECHENT C, Liopyris K, Monnier J, Aleissa S, et al
    Reflectance confocal microscopy terminology glossary for melanocytic skin lesions: A systematic review.
    J Am Acad Dermatol. 2021;84:102-119.
    PubMed     Abstract available


    December 2020
  266. SHANNON AB, Sharon CE, Straker RJ 3rd, Miura JT, et al
    The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33225.
    PubMed    


  267. MIGUEL BAF, Morgado-Carrasco D, Toll A, Perez-Anker J, et al
    Meshed keystone flap: A last-step modification to reduce tension and cover a larger surface.
    J Am Acad Dermatol. 2020;83:e397-e398.
    PubMed    


    November 2020
  268. DIKA E, Mastroeni S, Lambertini M, Scarfi F, et al
    The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33097.
    PubMed    


  269. ALLAIS BS, Beatson M, Wang H, Shahbazi S, et al
    Five-Year Survival in Patients with Nodular and Superficial Spreading Melanomas in the US Population.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33094.
    PubMed     Abstract available


  270. BARRIOS DM, Do MH, Phillips GS, Postow MA, et al
    Immune checkpoint inhibitors to treat cutaneous malignancies.
    J Am Acad Dermatol. 2020;83:1239-1253.
    PubMed     Abstract available


    October 2020
  271. BEHBAHANI S, Malerba S, Maniar A, Taback B, et al
    Outcomes and Predictors of Survival in Cutaneous Melanoma of the Eyelid: An Analysis of the National Cancer Database.
    J Am Acad Dermatol. 2020 Oct 31. pii: S0190-9622(20)32903.
    PubMed    


  272. KELM RC, Ali Y, Orrell K, Rangel SM, et al
    Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
    J Am Acad Dermatol. 2020 Oct 24. pii: S0190-9622(20)32862.
    PubMed    


  273. NAVARRETE-DECHENT C, Aleissa S, Connolly K, Hibler BP, et al
    Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
    J Am Acad Dermatol. 2020 Oct 20. pii: S0190-9622(20)32835.
    PubMed     Abstract available


  274. SISCOS SM, Neill BC, Seger EW, Rajpara A, et al
    Practice habits of Mohs surgeons treating melanoma with Mohs surgery: a cross-sectional survey.
    J Am Acad Dermatol. 2020 Oct 3. pii: S0190-9622(20)32682.
    PubMed    


  275. SHI K, Kim D, Mohan LS, Garfield EM, et al
    A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy.
    J Am Acad Dermatol. 2020;83:1028-1034.
    PubMed     Abstract available


  276. KINSER K, Barlow CE, Leonard D, Farrell SW, et al
    Tanning bed use and depression in a preventive medicine cohort: The Cooper Center Longitudinal Study.
    J Am Acad Dermatol. 2020;83:1200-1202.
    PubMed    


  277. YELAMOS O, Manubens E, Jain M, Chavez-Bourgeois M, et al
    Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers.
    J Am Acad Dermatol. 2020;83:1057-1063.
    PubMed     Abstract available


    July 2020
  278. SOLEYMANI T, Swetter SM, Hollmig ST, Aasi SZ, et al
    Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
    J Am Acad Dermatol. 2020;83:254-255.
    PubMed    


    June 2020
  279. JAFRY MA, Peacock S, Radick AC, Shucard HL, et al
    Pathologists' agreement on treatment suggestions for melanocytic skin lesions.
    J Am Acad Dermatol. 2020;82:1435-1444.
    PubMed     Abstract available


    May 2020
  280. PEREZ-ANKER J, Puig S, Malvehy J
    A fast and effective option for tissue flattening: Optimizing time and efficacy in ex vivo confocal microscopy.
    J Am Acad Dermatol. 2020;82:e157-e158.
    PubMed    


    April 2020
  281. FRIEDMAN BJ, Lee JB
    Spitz nevi in older adults: Correlation of histopathology with results of a gene expression profiling assay.
    J Am Acad Dermatol. 2020;82:1021-1023.
    PubMed    


  282. BATCHELDER E, Straight C, Butt M, Kirby JS, et al
    Information framing effects on patients' decisions about dysplastic nevus management.
    J Am Acad Dermatol. 2020;82:1011-1013.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.